Churchill P C, Rossi N F, Churchill M C, Ellis V R
Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201.
Life Sci. 1990;46(26):1953-9. doi: 10.1016/0024-3205(90)90511-o.
There is evidence that three inhibitors of Na,K-ATPase activity--ouabain, K-free extracellular fluid, and vanadate--inhibit renin secretion by increasing Ca2+ concentration in juxtaglomerular cells, but in the case of vanadate, it is uncertain whether the increase in Ca2+ is due to a decrease in Ca2+ efflux (inhibition of Ca-ATPase activity, or inhibition of Na,K-ATPase activity, followed by an increase in intracellular Na+ and a decrease in Na-Ca exchange) or to an increase in Ca2+ influx through potential operated Ca channels (inhibition of electrogenic Na,K transport, followed by membrane depolarization and activation of Ca channels). In the present experiments, the rat renal cortical slice preparation was used to compare and contrast the effects of ouabain, of K-free fluid, and of vanadate on renin secretion, in the absence and presence of methoxyverapamil, a Ca channel blocker. Basal renin secretory rate averaged 7.7 +/- 0.3 GU/g/60 min, and secretory rate was reduced to nearly zero by 1 mM ouabain, by K-free fluid, by 0.5 mM vanadate, and by K-depolarization (increasing extracellular K+ to 60 mM). Although 0.5 microM methoxyverapamil completely blocked the inhibitory effect of K-depolarization, it failed to antagonize the inhibitory effects of ouabain, of K-free fluid, and of vanadate. A concentration of methoxyverapamil two hundred times higher (100 microM) completely blocked the inhibitory effects of vanadate, but still failed to antagonize the effects of ouabain and of K-free fluid. Collectively, these observations demonstrate that vanadate-induced inhibition of renin secretion cannot be attributed entirely to Na,K-ATPase inhibition, since in the presence of methoxyverapamil, the effect of vanadate differed from the effects of either ouabain (a specific Na,K-ATPase inhibitor) or K-free fluid. Moreover, it cannot be attributed entirely to a depolarization-induced influx of Ca2+ through potential-operated Ca channels, since methoxyverapamil antagonized K-depolarization-induced inhibition of renin secretion much more effectively than it antagonized vanadate-induced inhibition.
有证据表明,三种钠钾ATP酶活性抑制剂——哇巴因、无钾细胞外液和钒酸盐——通过增加球旁细胞内的钙离子浓度来抑制肾素分泌,但就钒酸盐而言,钙离子的增加是由于钙离子外流减少(抑制钙ATP酶活性,或抑制钠钾ATP酶活性,随后细胞内钠离子增加,钠钙交换减少)还是由于通过电压门控钙通道的钙离子内流增加(抑制电生性钠钾转运,随后膜去极化和钙通道激活)尚不确定。在本实验中,使用大鼠肾皮质切片制备物,在有无钙通道阻滞剂甲氧基维拉帕米的情况下,比较和对比哇巴因、无钾液体和钒酸盐对肾素分泌的影响。基础肾素分泌率平均为7.7±0.3 GU/g/60分钟,1 mM哇巴因、无钾液体、0.5 mM钒酸盐和钾去极化(将细胞外钾离子增加到60 mM)可使分泌率降至几乎为零。虽然0.5 μM甲氧基维拉帕米完全阻断了钾去极化的抑制作用,但它未能拮抗哇巴因、无钾液体和钒酸盐的抑制作用。浓度高出200倍(100 μM)的甲氧基维拉帕米完全阻断了钒酸盐的抑制作用,但仍然未能拮抗哇巴因和无钾液体的作用。总的来说,这些观察结果表明,钒酸盐诱导的肾素分泌抑制不能完全归因于钠钾ATP酶抑制,因为在甲氧基维拉帕米存在的情况下,钒酸盐的作用不同于哇巴因(一种特异性钠钾ATP酶抑制剂)或无钾液体的作用。此外,它也不能完全归因于去极化诱导的通过电压门控钙通道的钙离子内流,因为甲氧基维拉帕米拮抗钾去极化诱导的肾素分泌抑制比拮抗钒酸盐诱导的抑制更有效。